# L-carnosine for Schizophrenia

> **NCT00177177** · NA · COMPLETED · sponsor: **University of Pittsburgh** · enrollment: 84 (estimated)

## Conditions studied

- Schizophrenia
- Schizoaffective Disorder

## Interventions

- **DRUG:** L-carnosine (dietary supplement)

## Key facts

- **NCT ID:** NCT00177177
- **Lead sponsor:** University of Pittsburgh
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-03
- **Primary completion:** 2007-11
- **Final completion:** 2007-12
- **Target enrollment:** 84 (ESTIMATED)
- **Last updated:** 2013-01-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00177177

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00177177, "L-carnosine for Schizophrenia". Retrieved via AI Analytics 2026-08-18 from https://api.ai-analytics.org/clinical/NCT00177177. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*